The potential factors considered in the analysis included gender, age, fever, CRP subgroups (<6.23 and ≥6.23), splenomegaly, administration of antibiotics, presence of anti-HLA-I antibodies, number of pregnancies, and the type of hematologic disease. This evidence concerns the gene CRP and Splenomegaly.